Literature DB >> 9258802

Developmental patterns of serum 3 alpha-androstanediol glucuronide.

H L Rittner1, P D Lee, W F Blum, H G Doerr, J Steiss, J Kreuder, W Rascher, W Kiess.   

Abstract

3 alpha-androstanediol glucuronide (3 alpha diolG) is a marker of peripheral tissue androgen metabolism. There are no previous data regarding complete paediatric reference ranges for 3 alpha diolG. In order to obtain reference values for 3 alpha diolG we have measured serum levels of 3 alpha diolG in 283 healthy children and adolescents, 146 boys and 137 girls, age 1 month to 20 years and 28 adults. A non-extraction, solid phase radioimmunoassay employing a polyclonal antiserum that is specific for 3 alpha diolG was used to measure serum 3 alpha diolG levels (intra assay variation 5.1-10.1%, inter assay variation 2.7-9.0%). There was a strong sex and age dependence (r = 0.8; p < 0.0001) of 3 alpha diolG levels throughout childhood and adolescence with males showing significantly higher levels of the androgen than females (p < 0.05). 3 alpha diolG serum levels (nmol/l +/- SD) correlated significantly with pubertal stage (p < 0.01). Interestingly, in 35 children with CAH serum 3 alpha diolG levels correlated well with clinical and metabolic status, i.e. 17OHP serum levels. In summary, we have established percentile curves for 3 alpha diolG levels in healthy children and adolescents. We hypothesize that on the basis of our reference values the single measurement of serum 3 alpha diolG could serve as a means to determine androgen status in children with disorders of puberty and sexual development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9258802     DOI: 10.1007/bf03350295

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Reference values for androstanediol glucuronide.

Authors:  M André; J Valsamis
Journal:  Clin Chem       Date:  1994-01       Impact factor: 8.327

2.  Serum 3 alpha-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy.

Authors:  B J Reiner; P A Donohoue; C J Migeon; G D Berkovitz
Journal:  J Clin Endocrinol Metab       Date:  1989-07       Impact factor: 5.958

3.  Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women.

Authors:  A W Meikle; W D Odell
Journal:  Fertil Steril       Date:  1986-08       Impact factor: 7.329

4.  Measurements of 3 alpha,17 beta-androstanediol glucuronide in serum and urine and the correlation with skin 5 alpha-reductase activity.

Authors:  R J Paulson; P C Serafini; J A Catalino; R A Lobo
Journal:  Fertil Steril       Date:  1986-08       Impact factor: 7.329

5.  Origin of plasma androstanediol glucuronide in men.

Authors:  E Moghissi; F Ablan; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1984-09       Impact factor: 5.958

6.  5 alpha-androstane-3 alpha, 17 beta-diol and 5 alpha-androstane-3 alpha, 17 beta-diol-glucuronide in plasma of normal children, adults and patients with idiopathic hirsutism: a mass spectrometric study.

Authors:  S A Wudy; U A Wachter; J Homoki; W M Teller
Journal:  Eur J Endocrinol       Date:  1996-01       Impact factor: 6.664

7.  17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.

Authors:  K von Schnakenburg; F Bidlingmaier; D Knorr
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

8.  Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction.

Authors:  M J Scanlon; C B Whorwood; S Franks; M J Reed; V H James
Journal:  Clin Endocrinol (Oxf)       Date:  1988-11       Impact factor: 3.478

9.  Serum 3 alpha-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia.

Authors:  S Hatun; N Yordam; A S Calikoğlu
Journal:  Eur J Endocrinol       Date:  1994-11       Impact factor: 6.664

10.  Physiopathology of plasma androstanediol-glucuronide.

Authors:  A Vermeulen; V A Giagulli
Journal:  J Steroid Biochem Mol Biol       Date:  1991-11       Impact factor: 4.292

View more
  1 in total

1.  Serum androgen levels in adolescents with type 1 diabetes: relationship to pubertal stage and metabolic control.

Authors:  K Meyer; J Deutscher; M Anil; A Berthold; M Bartsch; W Kiess
Journal:  J Endocrinol Invest       Date:  2000-06       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.